EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis

Zhiling Cheng, Meiling Gao, Yang Liu, Wei Yan, Zhihan Zhang, Ning Jiao, Congxin Li

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2024.10.017 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Zhiling Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang, Hebei, China; Hebei Medical Uni…. Hauptthemen laut MEDLINE: Hypercholesterolemia, Lipids, Anticholesteremic Agents, PCSK9 Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hebei Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaLipidsAnticholesteremic AgentsPCSK9 InhibitorsHumansTreatment OutcomeRandomized Controlled Trials as TopicMiddle AgedMaleFemaleBiomarkersCholesterol, LDLAgedProprotein Convertase 9AdultRNA, Small InterferingApolipoprotein B-100

Stichwörter der Autor:innen

EfficacyHyperlipidemiaInclisiranMeta-analysisSafety

Substanzen

PCSK9 protein, humanBiomarkersCholesterol, LDLLipidsProprotein Convertase 9Anticholesteremic AgentsALN-PCSAPOB protein, humanPCSK9 InhibitorsRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Pharmacy, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang, Hebei, China; Hebei Medical University, No. 361 Zhongshan East Road, Chang'an District, Shijiazhuang,…
  • Department of Pharmacy, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang, Hebei, China.
  • Department of Nutrition, The Fourth Hospital of Hebei Medical University, No. 12 Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China.
  • Department of Pharmacy, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang, Hebei, China. Electronic address: jn8026@126.com.
  • Department of Pharmacy, Hebei Medical University Third Hospital, No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang, Hebei, China. Electronic address: congxinli@hebmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Hebei Provincial Natural Science Foundation

Zitieren

APA

Cheng, Z., Gao, M., Liu, Y., Yan, W., Zhang, Z., Jiao, N., & Li, C. (2025). Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2024.10.017

Vancouver

Cheng Z, Gao M, Liu Y, Yan W, Zhang Z, Jiao N, et al. Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2024.10.017

BibTeX
@article{Cheng2025,
  author = {Cheng, Zhiling and Gao, Meiling and Liu, Yang and Yan, Wei and Zhang, Zhihan and Jiao, Ning and Li, Congxin},
  title = {Safety and efficacy of inclisiran in treating hypercholesterolemia: A systemic review and meta-analysis},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2024.10.017}
}
Kostenlos starten →